See also this year's filing and all EDGAR filings for this company.
PDF Report 0001270073_2023_Intercept_Pharmaceuticals_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001270073, Intercept Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 540,127,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 987,000 |
| 3 | remainder_Assets | 12,597,000 |
| 4 | LiabilitiesCurrent | 230,077,000 |
| 5 | LiabilitiesNoncurrent | 230,557,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | -2,194,124 |
| 8 | SellingGeneralAndAdministrativeExpense | 141,054,089 |
| 9 | ResearchAndDevelopmentExpense | 174,810,039 |
| 10 | remainder_Expenses | -29,704 |
| 11 | remainder_Revenues | 186,097,567 |
| 12 | remainder_NetIncome | 1,903,824,232 |
| 13 | remainder_ComprehensiveNetIncome | -421,759 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 553,711,000 |
| 1 | Liabilities | 460,634,000 |
| 2 | Expenses | 313,640,300 |
| 3 | Revenues | 186,097,567 |
| 4 | StockholdersEquity | 93,077,000 |
| 5 | NetIncome | 1,776,281,499 |
| 6 | ComprehensiveNetIncome | 1,776,070,620 |
| 7 | BaseVar | 1,709,164,429 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.90 |
| 9 | EconomicCapitalRatio | 4.32 |
Edgar->Model Mapping
Feature Distribution
Change over Time
